Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Ani Pharmaceuticals executive sells shares worth over $16k

Published 04/15/2024, 06:31 PM

In a recent transaction, Meredith (NYSE:MDP) Cook, the Senior Vice President, General Counsel, & Secretary of ANI Pharmaceuticals Inc. (NASDAQ:ANIP), sold 250 shares of the company's common stock. The transaction took place on April 12, 2024, and was executed at a price of $67.79 per share, totaling approximately $16,947.

This sale was carried out in accordance with a Rule 10b5-1 trading plan, which Cook had previously adopted on August 11, 2023. Such plans allow company insiders to set up a predetermined schedule for buying or selling shares at a time when they are not in possession of material non-public information, providing a defense against potential accusations of insider trading.

Following the sale, Cook still retains a significant stake in the company, with 59,731 shares of ANI Pharmaceuticals Inc. remaining in their possession. The transaction was reported in a Form 4 filing with the Securities and Exchange Commission, which provides transparency into the trading activities of the company's insiders.

Investors and the market often monitor insider transactions as they can provide insights into an insider’s view of the company's future prospects. However, these transactions can be motivated by various factors and may not necessarily be indicative of the company's operational performance or outlook.

ANI Pharmaceuticals Inc., headquartered in Baudette, Minnesota, specializes in the development and manufacturing of pharmaceutical products. The company's shares are publicly traded on the NASDAQ stock exchange under the ticker symbol ANIP.

InvestingPro Insights

ANI Pharmaceuticals Inc. (NASDAQ:ANIP) has shown a notable performance in the market with a year-to-date price total return of 22.58% and an impressive one-year price total return of 75.92%. As of the last close, the stock was trading at $66.88, which is near its 52-week high, with the price at 95.45% of this peak. This suggests a bullish sentiment among investors and aligns with the expectations of growth as reflected in the company's metrics.

3rd party Ad. Not an offer or recommendation by See disclosure here or remove ads .

From a valuation perspective, ANIP is trading at a high earnings multiple, with a P/E ratio of 76.64 and an adjusted P/E ratio for the last twelve months as of Q4 2023 at 80.76. However, the PEG ratio for the same period stands at 0.71, indicating potential growth relative to the earnings multiple. This could be a point of interest for investors looking for growth stocks with reasonable valuation ratios. Additionally, the company has demonstrated strong revenue growth of 53.87% over the last twelve months as of Q4 2023, suggesting robust operational performance.

An InvestingPro Tip that stands out is the company's expected net income growth this year, an important factor for potential investors considering the future profitability of ANIP. Moreover, two analysts have revised their earnings upwards for the upcoming period, further reinforcing the positive outlook on the company's financial health. For those interested in deeper analysis, there are 13 additional InvestingPro Tips available, which can be accessed by visiting As a bonus, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, enriching your investment research with valuable insights.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.